John F. Heerdink, Jr.
@johnfheerdinkjr
Followers
2K
Following
17K
Media
2K
Statuses
18K
Advisor, Investor, & Entrepreneur. Managing Member of Vista Partners LLC & Tribe Public, LLC. Opinions not recommendations. https://t.co/8pLWFhEpfC
San Francisco, CA
Joined March 2020
Modular Medical Appoints Insulin Pump Veteran, Eyes Aggressive Global Rollout for Pivot Device – ( $MODD $PODD ) https://t.co/dT1yDFwql8
#ModularMedical #MODD #DiabetesTech #InsulinPump #PivotPump #MedicalDevices #Type1Diabetes #Type2Diabetes #DiabetesCare #PatchPump
vistapglobal.com
Modular Medical (NASDAQ: MODD) is entering a transformational phase with the appointment of David Bosshard as Head of International Operations, marking the company’s most ambitious push toward global...
0
2
2
Bristol Myers Squibb Doubles Down on Innovation With Orbital and RayzeBio Acquisitions -( $BMY $IBB $XBI ) https://t.co/TpIljITRPc
#PharmaInnovation
#Biopharma
#Immunotherapy
#Oncology
#Acquisition
#DrugDevelopment
#Healthcare
#AntibodyTherapy
#ClinicalTrials
#NextGenMedicine
0
1
1
Oklo’s Innovative Fast Reactor Seeks To Power U.S. Clean Energy Future with DOE Support - ( $OKLO $XLE )
vistapglobal.com
Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company based in Santa Clara, California, has been selected by the U.S. Department of Energy (DOE) for a pivotal initiative to pilot advanced...
0
1
0
Investors Eye Eupraxia’s Breakthroughs as Tribe Public Brings CEO to the Forefront on October 14 -( $EPRX $IBB $XBI ) https://t.co/RGPx4D3XFP
vistapglobal.com
Tribe Public’s next CEO Presentation and Q&A Webinar Event is scheduled for Tuesday, October 14 at 9 a.m. Pacific, spotlighting Eupraxia Pharmaceuticals (NASDAQ: EPRX) at a critical juncture in its...
0
1
2
$INTG The InterGroup has surged 16.94% to $23.75 on #Friday Check it out on Yahoo Finance https://t.co/hfOGhj1YEg $EPRX $NVDA $SER $OKLO #Letsgo #StocksInFocus
0
0
0
Investors Eye Eupraxia’s Breakthroughs as Tribe Public Brings CEO to the Forefront on October 14 -( $EPRX $IBB $XBI ) https://t.co/RGPx4D3XFP
vistapglobal.com
Tribe Public’s next CEO Presentation and Q&A Webinar Event is scheduled for Tuesday, October 14 at 9 a.m. Pacific, spotlighting Eupraxia Pharmaceuticals (NASDAQ: EPRX) at a critical juncture in its...
0
1
2
Oklo’s Innovative Fast Reactor Seeks To Power U.S. Clean Energy Future with DOE Support - ( $OKLO $XLE )
vistapglobal.com
Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company based in Santa Clara, California, has been selected by the U.S. Department of Energy (DOE) for a pivotal initiative to pilot advanced...
0
1
0
Bristol Myers Squibb Doubles Down on Innovation With Orbital and RayzeBio Acquisitions -( $BMY $IBB $XBI ) https://t.co/TpIljITRPc
#PharmaInnovation
#Biopharma
#Immunotherapy
#Oncology
#Acquisition
#DrugDevelopment
#Healthcare
#AntibodyTherapy
#ClinicalTrials
#NextGenMedicine
0
1
1
Novo Nordisk’s $5.2 Billion Bet on Liver Disease: Why Akero’s Efruxifermin May Be The Next Obesity-Linked Blockbuster -( $NVO $AKRO $RHHBY $IBB $XBI ) https://t.co/slD9cTFiO6
#Biotechnology #LifeSciences #Pipeline #FDA #Genomics #Biopharma #PharmaNews #MarketUpdate
vistapglobal.com
In a move signaling Novo Nordisk’s (NVO) sharpened ambitions beyond diabetes and obesity, the Danish pharmaceutical giant announced on Thursday its intent to acquire Akero Therapeutics (AKRO) for as...
0
2
3
Market Movers October 9: AMD, Apple, NVIDIA Lead Declines, Treasury Yields Rise, Gold & Bitcoin Slip -( $AKRO $EPRX $INTC $LLY $MDB $META $MODD $NVDA $OKLO $ORCL $PLTR $RHHBY Rise!) https://t.co/8BHQGT3iEk
#IPO #Merger #Acquisition #Tariffs #YieldCurve #FOMC #Gold #Silver
vistapglobal.com
On Thursday, October 9, 2025, all major U.S. indices moved lower amidst persistent investor caution and renewed concerns around interest rates and growth. The S&P 500 declined by 0.28% to close at...
0
2
2
Market Movers October 9: AMD, Apple, NVIDIA Lead Declines, Treasury Yields Rise, Gold & Bitcoin Slip -( $AKRO $EPRX $INTC $LLY $MDB $META $MODD $NVDA $OKLO $ORCL $PLTR $RHHBY Rise!) https://t.co/xf2iH9aEVG
#TreasuryYields #FOMC #Gold #Silver #Oil #Bitcoin #Crypto #WallStreet
vistapglobal.com
On Thursday, October 9, 2025, all major U.S. indices moved lower amidst persistent investor caution and renewed concerns around interest rates and growth. The S&P 500 declined by 0.28% to close at...
0
2
2
GeoVax CEO, David Dodd, will participate in the 4th Annual ROTH Healthcare Opportunities Conference, taking place on Thursday, October 9, 2025, at the Yale Club in NYC. Investors seeking to schedule a meeting should contact their ROTH representative. https://t.co/bUuTPBk03t $GOVX
1
1
4
Game Changer for Immunocompromised? GeoVax Makes Case at World Vaccine Congress Europe 2025 -( $GOVX $IBB $XBI )
vistapglobal.com
GeoVax Labs (NASDAQ: GOVX) is advancing its multi-antigen COVID-19 vaccine, GEO-CM04S1, with fresh clinical data set to take center stage at the World Vaccine Congress Europe 2025, Europe’s largest...
1
2
3
Game Changer for Immunocompromised? GeoVax Makes Case at World Vaccine Congress Europe 2025 -( $GOVX $IBB $XBI )
vistapglobal.com
GeoVax Labs (NASDAQ: GOVX) is advancing its multi-antigen COVID-19 vaccine, GEO-CM04S1, with fresh clinical data set to take center stage at the World Vaccine Congress Europe 2025, Europe’s largest...
1
2
2
Market Movers October 9: AMD, Apple, NVIDIA Lead Declines, Treasury Yields Rise, Gold & Bitcoin Slip -( $AKRO $EPRX $INTC $LLY $MDB $META $MODD $NVDA $OKLO $ORCL $PLTR $RHHBY Rise!) https://t.co/8o2tCFl1ru
#StockMarket #DowJones #Nasdaq #Russell2000 #MarketUpdate #Investing
vistapglobal.com
On Thursday, October 9, 2025, all major U.S. indices moved lower amidst persistent investor caution and renewed concerns around interest rates and growth. The S&P 500 declined by 0.28% to close at...
0
3
3
Market Movers October 9: AMD, Apple, NVIDIA Lead Declines, Treasury Yields Rise, Gold & Bitcoin Slip -( $AKRO $EPRX $INTC $LLY $MDB $META $MODD $NVDA $OKLO $ORCL $PLTR $RHHBY Rise!) https://t.co/8o2tCFl1ru
#StockMarket #DowJones #Nasdaq #Russell2000 #MarketUpdate #Investing
vistapglobal.com
On Thursday, October 9, 2025, all major U.S. indices moved lower amidst persistent investor caution and renewed concerns around interest rates and growth. The S&P 500 declined by 0.28% to close at...
0
3
3
Novo Nordisk’s $5.2 Billion Bet on Liver Disease: Why Akero’s Efruxifermin May Be The Next Obesity-Linked Blockbuster -( $NVO $AKRO $RHHBY $IBB $XBI ) https://t.co/Kjcd8YrrXg
#Biotech #Pipeline #FDA #Genomics #Microbiology #Biopharma #Research #HealthcareLeadership $EPRX $GOVX
vistapglobal.com
In a move signaling Novo Nordisk’s (NVO) sharpened ambitions beyond diabetes and obesity, the Danish pharmaceutical giant announced on Thursday its intent to acquire Akero Therapeutics (AKRO) for as...
0
2
2
Game Changer for Immunocompromised? GeoVax Makes Case at World Vaccine Congress Europe 2025 -( $GOVX $IBB $XBI )
1
0
0